Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Genomics02:02

Genomics

40.4K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
40.4K
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

553
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
553
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

272
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
272
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

326
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
326
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

246
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
246
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

529
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
529

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Sedentary behaviour and cancer risk: a World Cancer Research Fund International Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis.

medRxiv : the preprint server for health sciences·2026
Same author

Sugar sweetened and artificially sweetened beverages, fruit and vegetable juices and cancer risk: a World Cancer Research Fund International Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis.

medRxiv : the preprint server for health sciences·2026
Same author

Synthesis and Investigation of a Novel Platinum(II) Complex Targeting Biotin Receptor-Positive Tumors: In Vitro Evaluation in Cisplatin-Sensitive and -Resistant Cells, Mass Cytometry Profiling, Pharmacokinetics, In Vivo Efficacy, and SMVT-Mediated Uptake.

ACS omega·2026
Same author

Common and rare variant analyses implicate <i>JARID2</i> in cerebral tau deposition.

NPJ dementia·2026
Same author

Evaluation of the 4Kscore in EPIC: Reply.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Epigenetic silencing of miR-141 via core promoter methylation is associated with short-term bladder cancer progression.

The Journal of biological chemistry·2026

相关实验视频

Updated: Jan 29, 2026

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
07:11

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

3.3K

综合基因组和新陈代谢数据的多原子方法突出显示了结肠直肠癌途径.

Aikaterini Iliou1, Elena Chekmeneva2, Rui Climaco Pinto2,3

  • 1Division of Pharmaceutical Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens, 157 71 Athens, Greece.

Journal of proteome research
|January 28, 2026
PubMed
概括

将遗传和代谢数据整合起来,揭示了RHPN2基因中的关键结直肠癌 (CRC) 风险位置. 这个内部区域影响细胞生长和代谢过程,为CRC发育提供了新的见解.

关键词:
在GWAS中,GWAS就是GWAS.在Rho GTPase中.结肠直肠癌是什么意思代谢生物组的代谢生物组多种多种多种多种多种多种多种多种多种多种.尿液 尿液 尿液

更多相关视频

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.8K
Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
07:35

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Published on: June 8, 2020

7.4K

相关实验视频

Last Updated: Jan 29, 2026

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
07:11

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

3.3K
Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.8K
Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
07:35

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Published on: June 8, 2020

7.4K

科学领域:

  • 遗传学 是一个遗传学.
  • 代谢学 代谢学 代谢学
  • 癌症生物学 癌症生物学

背景情况:

  • 全基因组关联研究 (GWAS) 已经确定了许多与结直肠癌 (CRC) 风险相关的遗传变异.
  • 了解这些变异的功能影响对于阐明CRC病原性至关重要.

研究的目的:

  • 调查CRC相关遗传变异和尿路代谢产物之间的关联.
  • 探索已识别的基因位点在结直肠癌发展中的功能作用.

主要方法:

  • 使用基因组数据和非向的1H核磁共振 (NMR) 尿液代谢分析进行了全代谢组的关联分析.
  • 在结肠癌细胞中进行了功能性实验,包括CRISPR介导的基因编辑和RNA测序.

主要成果:

  • 七种结肠直肠癌 (CRC) 单核酸多态 (SNPs) 显示出与尿路代谢产物具有统计学意义的关联,包括与糖,氨基酸 (tyrosine,leucine) 和肠道微生物代谢产物的关联.
  • 结肠癌细胞中特定的RHPN2内在区域 (rs10411210) 的淘汰会影响细胞生长.
  • RNA测序揭示了RHPN2内基区域编辑后参与细胞分裂和代谢过程的基因的广泛放松调节.

结论:

  • 遗传和代谢数据的整合突出显示了RHPN2内在位点在结直肠癌 (CRC) 易感性中的重要性.
  • 这种位置可能会通过影响代谢物分泌的代谢途径影响CRC风险.